Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2019-10-07 1:32 pm Purchase | 13G | OCUGEN INC OCGN | Empery Asset Management LP | 18,491,223 6.48% | 18,491,223 (New Position) | View |
| 2019-09-25 2:37 pm Purchase | 13G | AETERNA ZENTARIS INC AEZS | Empery Asset Management LP | 1,661,000 6.64% | 1,661,000 (New Position) | View |
| 2019-08-15 1:28 pm Purchase | 13G | NOVABAY PHARMACEUTICALS INC CO NBY | Empery Asset Management LP | 2,098,566 8.42% | 2,098,566 (New Position) | View |
| 2019-08-06 1:28 pm Purchase | 13G | RESHAPE LIFESCIENCES INC C RSLS | Empery Asset Management LP | 550,000 9.99% | 550,000 (New Position) | View |
| 2019-06-20 3:46 pm Purchase | 13G | AMPIO PHARMACEUTICALS INC AMPE | Empery Asset Management LP | 12,500,000 8.84% | 12,500,000 (New Position) | View |
| 2019-06-05 2:19 pm Purchase | 13G | DELMAR PHARMACEUTICALS INC DMPI | Empery Asset Management LP | 292,500 7.65% | 292,500 (New Position) | View |